APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Culture Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cell Culture Service Market Outlook and Growth Opportunities 2026

12 August 2026200 pages

Choose your research edition.

Industry ResearchCell Culture Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Culture Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cell Culture Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Culture Service Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Culture Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Cell Culture Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cell Culture Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cell Culture Service market include Danaher, Lonza, WuXi Biologics, Samsung Biologics, Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, Evotec and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cell Culture Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Culture Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Culture Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell Culture Service market.

Cell Culture Service Segment by Company

Danaher

Lonza

WuXi Biologics

Samsung Biologics

Charles River Laboratories

Labcorp Drug Development

Eurofins Scientific

Evotec

Catalent

AGC Biologics

ProBioGen

Pharmaron

Takara Bio

AGC Biologics Japan

Thermo Fisher Scientific

Merck KGaA

Sartorius

Cell Culture Service Segment by Type

Primary Cells

Transformed Cells

Self-renewing Cells

Cell Culture Service Segment by Application

Research Institute

Hospital

Others

Cell Culture Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell Culture Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell Culture Service key companies, revenue, market share, and recent developments.

3. To split the Cell Culture Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell Culture Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell Culture Service significant trends, drivers, influence factors in global and regions.

6. To analyze Cell Culture Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Culture Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Culture Service industry.

Chapter 3: Detailed analysis of Cell Culture Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell Culture Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell Culture Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell Culture Service Industry Trends Table 2. Cell Culture Service Industry Drivers Table 3. Cell Culture Service Industry Opportunities and Challenges Table 4. Cell Culture Service Industry Restraints Table 5. Global Cell Culture Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell Culture Service Revenue Share by Company (2021-2026) Table 7. Global Cell Culture Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell Culture Service Key Company Manufacturing Base & Headquarters Table 9. Global Cell Culture Service Company, Product Type & Application Table 10. Global Cell Culture Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell Culture Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Primary Cells Table 15. Significant Companies of Transformed Cells Table 16. Significant Companies of Self-renewing Cells Table 17. Global Cell Culture Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cell Culture Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Cell Culture Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Cell Culture Service Sales Value Share by Type (2021-2026) Table 21. Global Cell Culture Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Research Institute Table 23. Significant Companies of Hospital Table 24. Significant Companies of Others Table 25. Global Cell Culture Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell Culture Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cell Culture Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cell Culture Service Sales Value Share by Application (2021-2026) Table 29. Global Cell Culture Service Sales Value Share by Application (2027-2032) Table 30. Global Cell Culture Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell Culture Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cell Culture Service Sales Value Share by Region (2021-2026) Table 33. Global Cell Culture Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cell Culture Service Sales Value Share by Region (2027-2032) Table 35. Global Cell Culture Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cell Culture Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cell Culture Service Sales Value Market Share by Country (2021-2026) Table 38. Global Cell Culture Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cell Culture Service Sales Value Market Share by Country (2027-2032) Table 40. Danaher Company Information Table 41. Danaher Business Overview Table 42. Danaher Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Danaher Cell Culture Service Product Portfolio Table 44. Danaher Recent Development Table 45. Lonza Company Information Table 46. Lonza Business Overview Table 47. Lonza Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Lonza Cell Culture Service Product Portfolio Table 49. Lonza Recent Development Table 50. WuXi Biologics Company Information Table 51. WuXi Biologics Business Overview Table 52. WuXi Biologics Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. WuXi Biologics Cell Culture Service Product Portfolio Table 54. WuXi Biologics Recent Development Table 55. Samsung Biologics Company Information Table 56. Samsung Biologics Business Overview Table 57. Samsung Biologics Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Samsung Biologics Cell Culture Service Product Portfolio Table 59. Samsung Biologics Recent Development Table 60. Charles River Laboratories Company Information Table 61. Charles River Laboratories Business Overview Table 62. Charles River Laboratories Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Charles River Laboratories Cell Culture Service Product Portfolio Table 64. Charles River Laboratories Recent Development Table 65. Labcorp Drug Development Company Information Table 66. Labcorp Drug Development Business Overview Table 67. Labcorp Drug Development Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Labcorp Drug Development Cell Culture Service Product Portfolio Table 69. Labcorp Drug Development Recent Development Table 70. Eurofins Scientific Company Information Table 71. Eurofins Scientific Business Overview Table 72. Eurofins Scientific Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Eurofins Scientific Cell Culture Service Product Portfolio Table 74. Eurofins Scientific Recent Development Table 75. Evotec Company Information Table 76. Evotec Business Overview Table 77. Evotec Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Evotec Cell Culture Service Product Portfolio Table 79. Evotec Recent Development Table 80. Catalent Company Information Table 81. Catalent Business Overview Table 82. Catalent Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Catalent Cell Culture Service Product Portfolio Table 84. Catalent Recent Development Table 85. AGC Biologics Company Information Table 86. AGC Biologics Business Overview Table 87. AGC Biologics Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AGC Biologics Cell Culture Service Product Portfolio Table 89. AGC Biologics Recent Development Table 90. ProBioGen Company Information Table 91. ProBioGen Business Overview Table 92. ProBioGen Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. ProBioGen Cell Culture Service Product Portfolio Table 94. ProBioGen Recent Development Table 95. Pharmaron Company Information Table 96. Pharmaron Business Overview Table 97. Pharmaron Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Pharmaron Cell Culture Service Product Portfolio Table 99. Pharmaron Recent Development Table 100. Takara Bio Company Information Table 101. Takara Bio Business Overview Table 102. Takara Bio Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Takara Bio Cell Culture Service Product Portfolio Table 104. Takara Bio Recent Development Table 105. AGC Biologics Japan Company Information Table 106. AGC Biologics Japan Business Overview Table 107. AGC Biologics Japan Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. AGC Biologics Japan Cell Culture Service Product Portfolio Table 109. AGC Biologics Japan Recent Development Table 110. Thermo Fisher Scientific Company Information Table 111. Thermo Fisher Scientific Business Overview Table 112. Thermo Fisher Scientific Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Thermo Fisher Scientific Cell Culture Service Product Portfolio Table 114. Thermo Fisher Scientific Recent Development Table 115. Merck KGaA Company Information Table 116. Merck KGaA Business Overview Table 117. Merck KGaA Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Merck KGaA Cell Culture Service Product Portfolio Table 119. Merck KGaA Recent Development Table 120. Sartorius Company Information Table 121. Sartorius Business Overview Table 122. Sartorius Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Sartorius Cell Culture Service Product Portfolio Table 124. Sartorius Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Cell Culture Service Product Image Figure 2. Global Cell Culture Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Culture Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell Culture Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Primary Cells Image Figure 8. Transformed Cells Image Figure 9. Self-renewing Cells Image Figure 10. Global Cell Culture Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Cell Culture Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Cell Culture Service Sales Value Share by Type (2021-2032) Figure 13. Research Institute Image Figure 14. Hospital Image Figure 15. Others Image Figure 16. Global Cell Culture Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cell Culture Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cell Culture Service Sales Value Share by Application (2021-2032) Figure 19. Global Cell Culture Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cell Culture Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Primary Cells
  • Transformed Cells
  • Self-renewing Cells
Applications
  • Research Institute
  • Hospital
  • Others
Companies covered
  • Danaher
  • Lonza
  • WuXi Biologics
  • Samsung Biologics
  • Charles River Laboratories
  • Labcorp Drug Development
  • Eurofins Scientific
  • Evotec
  • Catalent
  • AGC Biologics
  • ProBioGen
  • Pharmaron
  • Takara Bio
  • AGC Biologics Japan
  • Thermo Fisher Scientific
  • Merck KGaA
  • Sartorius

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell Culture Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell Culture Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell Culture Service Market Dynamics
  1. 2.1 Cell Culture Service Industry Trends
  2. 2.2 Cell Culture Service Industry Drivers
  3. 2.3 Cell Culture Service Industry Opportunities and Challenges
  4. 2.4 Cell Culture Service Industry Restraints
3 Cell Culture Service Market by Company
  1. 3.1 Global Cell Culture Service Company Revenue Ranking in 2025
  2. 3.2 Global Cell Culture Service Revenue by Company (2021-2026)
  3. 3.3 Global Cell Culture Service Company Ranking (2024-2026)
  4. 3.4 Global Cell Culture Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell Culture Service Company Product Type and Application
  6. 3.6 Global Cell Culture Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell Culture Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell Culture Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell Culture Service Market by Type
  1. 4.1 Cell Culture Service Type Introduction
  2. 4.1.1 Primary Cells
  3. 4.1.2 Transformed Cells
  4. 4.1.3 Self-renewing Cells
  5. 4.2 Global Cell Culture Service Sales Value by Type
  6. 4.2.1 Global Cell Culture Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cell Culture Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Cell Culture Service Sales Value Share by Type (2021-2032)
5 Cell Culture Service Market by Application
  1. 5.1 Cell Culture Service Application Introduction
  2. 5.1.1 Research Institute
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Cell Culture Service Sales Value by Application
  6. 5.2.1 Global Cell Culture Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cell Culture Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cell Culture Service Sales Value Share by Application (2021-2032)
6 Cell Culture Service Regional Value Analysis
  1. 6.1 Global Cell Culture Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell Culture Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell Culture Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell Culture Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell Culture Service Sales Value (2021-2032)
  7. 6.3.2 North America Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell Culture Service Sales Value (2021-2032)
  10. 6.4.2 Europe Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell Culture Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell Culture Service Sales Value (2021-2032)
  16. 6.6.2 South America Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell Culture Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell Culture Service Sales Value Share by Country, 2025 VS 2032
7 Cell Culture Service Country-level Value Analysis
  1. 7.1 Global Cell Culture Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell Culture Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell Culture Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell Culture Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell Culture Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell Culture Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell Culture Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell Culture Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell Culture Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell Culture Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell Culture Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell Culture Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell Culture Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell Culture Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell Culture Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell Culture Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell Culture Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell Culture Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell Culture Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell Culture Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell Culture Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell Culture Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell Culture Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell Culture Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell Culture Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell Culture Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell Culture Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell Culture Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell Culture Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell Culture Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell Culture Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell Culture Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell Culture Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Danaher
  2. 8.1.1 Danaher Company Information
  3. 8.1.2 Danaher Business Overview
  4. 8.1.3 Danaher Cell Culture Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Danaher Cell Culture Service Product Portfolio
  6. 8.1.5 Danaher Recent Developments
  7. 8.2 Lonza
  8. 8.2.1 Lonza Company Information
  9. 8.2.2 Lonza Business Overview
  10. 8.2.3 Lonza Cell Culture Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lonza Cell Culture Service Product Portfolio
  12. 8.2.5 Lonza Recent Developments
  13. 8.3 WuXi Biologics
  14. 8.3.1 WuXi Biologics Company Information
  15. 8.3.2 WuXi Biologics Business Overview
  16. 8.3.3 WuXi Biologics Cell Culture Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 WuXi Biologics Cell Culture Service Product Portfolio
  18. 8.3.5 WuXi Biologics Recent Developments
  19. 8.4 Samsung Biologics
  20. 8.4.1 Samsung Biologics Company Information
  21. 8.4.2 Samsung Biologics Business Overview
  22. 8.4.3 Samsung Biologics Cell Culture Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Samsung Biologics Cell Culture Service Product Portfolio
  24. 8.4.5 Samsung Biologics Recent Developments
  25. 8.5 Charles River Laboratories
  26. 8.5.1 Charles River Laboratories Company Information
  27. 8.5.2 Charles River Laboratories Business Overview
  28. 8.5.3 Charles River Laboratories Cell Culture Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Charles River Laboratories Cell Culture Service Product Portfolio
  30. 8.5.5 Charles River Laboratories Recent Developments
  31. 8.6 Labcorp Drug Development
  32. 8.6.1 Labcorp Drug Development Company Information
  33. 8.6.2 Labcorp Drug Development Business Overview
  34. 8.6.3 Labcorp Drug Development Cell Culture Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Drug Development Cell Culture Service Product Portfolio
  36. 8.6.5 Labcorp Drug Development Recent Developments
  37. 8.7 Eurofins Scientific
  38. 8.7.1 Eurofins Scientific Company Information
  39. 8.7.2 Eurofins Scientific Business Overview
  40. 8.7.3 Eurofins Scientific Cell Culture Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eurofins Scientific Cell Culture Service Product Portfolio
  42. 8.7.5 Eurofins Scientific Recent Developments
  43. 8.8 Evotec
  44. 8.8.1 Evotec Company Information
  45. 8.8.2 Evotec Business Overview
  46. 8.8.3 Evotec Cell Culture Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Evotec Cell Culture Service Product Portfolio
  48. 8.8.5 Evotec Recent Developments
  49. 8.9 Catalent
  50. 8.9.1 Catalent Company Information
  51. 8.9.2 Catalent Business Overview
  52. 8.9.3 Catalent Cell Culture Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Catalent Cell Culture Service Product Portfolio
  54. 8.9.5 Catalent Recent Developments
  55. 8.10 AGC Biologics
  56. 8.10.1 AGC Biologics Company Information
  57. 8.10.2 AGC Biologics Business Overview
  58. 8.10.3 AGC Biologics Cell Culture Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AGC Biologics Cell Culture Service Product Portfolio
  60. 8.10.5 AGC Biologics Recent Developments
  61. 8.11 ProBioGen
  62. 8.11.1 ProBioGen Company Information
  63. 8.11.2 ProBioGen Business Overview
  64. 8.11.3 ProBioGen Cell Culture Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ProBioGen Cell Culture Service Product Portfolio
  66. 8.11.5 ProBioGen Recent Developments
  67. 8.12 Pharmaron
  68. 8.12.1 Pharmaron Company Information
  69. 8.12.2 Pharmaron Business Overview
  70. 8.12.3 Pharmaron Cell Culture Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pharmaron Cell Culture Service Product Portfolio
  72. 8.12.5 Pharmaron Recent Developments
  73. 8.13 Takara Bio
  74. 8.13.1 Takara Bio Company Information
  75. 8.13.2 Takara Bio Business Overview
  76. 8.13.3 Takara Bio Cell Culture Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Takara Bio Cell Culture Service Product Portfolio
  78. 8.13.5 Takara Bio Recent Developments
  79. 8.14 AGC Biologics Japan
  80. 8.14.1 AGC Biologics Japan Company Information
  81. 8.14.2 AGC Biologics Japan Business Overview
  82. 8.14.3 AGC Biologics Japan Cell Culture Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AGC Biologics Japan Cell Culture Service Product Portfolio
  84. 8.14.5 AGC Biologics Japan Recent Developments
  85. 8.15 Thermo Fisher Scientific
  86. 8.15.1 Thermo Fisher Scientific Company Information
  87. 8.15.2 Thermo Fisher Scientific Business Overview
  88. 8.15.3 Thermo Fisher Scientific Cell Culture Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thermo Fisher Scientific Cell Culture Service Product Portfolio
  90. 8.15.5 Thermo Fisher Scientific Recent Developments
  91. 8.16 Merck KGaA
  92. 8.16.1 Merck KGaA Company Information
  93. 8.16.2 Merck KGaA Business Overview
  94. 8.16.3 Merck KGaA Cell Culture Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck KGaA Cell Culture Service Product Portfolio
  96. 8.16.5 Merck KGaA Recent Developments
  97. 8.17 Sartorius
  98. 8.17.1 Sartorius Company Information
  99. 8.17.2 Sartorius Business Overview
  100. 8.17.3 Sartorius Cell Culture Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sartorius Cell Culture Service Product Portfolio
  102. 8.17.5 Sartorius Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst